Evidence map›Paper›PMID 34235883›Full record

GuidelineArthritis & rheumatology (Hoboken, N.J.)2021

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa.

Sharon A Chung, Mark Gorelik, Carol A Langford, Mehrdad Maz, Andy Abril, Gordon Guyatt, Amy M Archer, Doyt L Conn, Kathy A Full, Peter C Grayson and 22 more

Open access · bronzeAbstract readPractice GuidelineSystematic Review
In one paragraph

Guideline in Arthritis & rheumatology (Hoboken, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Reproductive Outcomes for Women With Vasculitis.The Journal of rheumatology · 2024
    Article
  19. Multi-Modality Imaging in Vasculitis.Diagnostics (Basel, Switzerland) · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 2 countries.

Sharon A ChungUniversity of California, San Francisco.
Mark GorelikColumbia University, New York, New York.
Carol A LangfordCleveland Clinic Foundation, Cleveland, Ohio.
Mehrdad MazUniversity of Kansas Medical Center, Kansas City.ORCID 0000-0002-3594-0508
Andy AbrilMayo Clinic, Jacksonville, Florida.
Gordon GuyattMcMaster University, Hamilton, Ontario, Canada.
Amy M ArcherNorthwestern University, Chicago, Illinois.
Doyt L ConnEmory University, Atlanta, Georgia.ORCID 0000-0003-3303-3944
Kathy A FullSpringfield, Illinois.
Peter C GraysonNational Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.ORCID 0000-0002-8269-9438
Maria F IbarraChildren's Mercy Hospital, Kansas City, Missouri.
Lisa F ImundoColumbia University, New York, New York.
Susan KimUniversity of California, San Francisco.
Peter A MerkelUniversity of Pennsylvania, Philadelphia.ORCID 0000-0001-9284-7345
Rennie L RheeUniversity of Pennsylvania, Philadelphia.ORCID 0000-0002-4907-0304
Philip SeoJohns Hopkins University, Baltimore, Maryland.
John H StoneMassachusetts General Hospital, Boston.ORCID 0000-0001-6588-9435
Sangeeta SuleChildren's National, Washington, DC.ORCID 0000-0002-5876-376X
Robert P SundelBoston Children's Hospital, Boston, Massachusetts.
Omar I VitobaldiChicago, Illinois.
Ann WarnerSaint Luke's Health System, Kansas City, Missouri.
Kevin ByramVanderbilt University, Nashville, Tennessee.
Anisha B DuaNorthwestern University, Chicago, Illinois.
Nedaa HusainatSSM Health-St. Mary's Hospital, St Louis, Missouri.ORCID 0000-0002-9638-2992
Karen E JamesUniversity of Utah, Salt Lake City.
Mohamad KalotState University of New York at Buffalo.ORCID 0000-0002-6581-4561
Yih Chang LinUniversity of South Florida, Tampa.
Jason M SpringerUniversity of Kansas Medical Center, Kansas City.ORCID 0000-0002-3903-6049
Marat TurgunbaevAmerican College of Rheumatology, Atlanta, Georgia.
Alexandra Villa-ForteCleveland Clinic Foundation, Cleveland, Ohio.
Amy S TurnerAmerican College of Rheumatology, Atlanta, Georgia.ORCID 0000-0001-7695-2022
Reem A MustafaUniversity of Kansas Medical Center, Kansas City, and McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0002-2091-0875
University of Kansas Medical Center · USAmerican College of Rheumatology · USCleveland Clinic · USColumbia University · USNorthwestern University · USUniversity of California, San Francisco · USUniversity of Pennsylvania · USBoston Children's Hospital · USChildren's Mercy Hospital · USChildren's National · USEmory University · USJacksonville College · USJohns Hopkins University · USMassachusetts General Hospital · USMcMaster University · CANational Institute of Arthritis and Musculoskeletal and Skin Diseases · USSaint Luke's Health System · USSt. Mary's Hospital · USUniversity at Buffalo, State University of New York · USUniversity of Illinois at Springfield · US

Funding

Intramural NIH HHS Z99 AR999999
6 · The paper itself

Abstract

objectiveTo provide evidence-based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN).

methodsTwenty-one clinical questions regarding diagnostic testing, treatment, and management were developed in the population, intervention, comparator, and outcome (PICO) format for systemic, non-hepatitis B-related PAN. Systematic literature reviews were conducted for each PICO question. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to assess the quality of evidence and formulate recommendations. Each recommendation required ≥70% consensus among the Voting Panel.

resultsWe present 16 recommendations and 1 ungraded position statement for PAN. Most recommendations were graded as conditional due to the paucity of evidence. These recommendations support early treatment of severe PAN with cyclophosphamide and glucocorticoids, limiting toxicity through minimizing long-term exposure to both treatments, and the use of imaging and tissue biopsy for disease diagnosis. These recommendations endorse minimizing risk to the patient by using established therapy at disease onset and identify new areas where adjunctive therapy may be warranted.

conclusionThese recommendations provide guidance regarding diagnostic strategies, use of pharmacologic agents, and imaging for patients with PAN.

Indexed as

Polyarteritis NodosaAntirheumatic AgentsCyclophosphamideDisease ManagementEvidence-Based MedicineGlucocorticoidsHumansRheumatologyUnited StatesAntirheumatic AgentsCyclophosphamideGlucocorticoids

Identifiers

PMID34235883
PMCPMC12323812
OpenAlexW3180539770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.